CUSIP: 45333F208 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 27 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13GPolar Asset Management Partners Inc. | 900,000 | 7.0% | New 5%+ stake | Jun 30, 2026 | 625,000 sh (Mar 31, 2026) |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 168,305 | $545.3K | 0.1% | Deep Value | Very High | Bethesda, MD | 2026-11-09 | |
| 153,139 | $496.2K | 0.0% | Index | Very Low | Fort Mill, SC | 2026-11-06 | |
| 14,029 | $45.5K | 0.0% | ETF | Low | Waltham, MA | 2026-11-02 | |
| 2,007 | $6.5K | 0.0% | Core | Medium | Zurich, Switzerland | 2026-11-10 | |
| 1,928 | $4.3K | 0.0% | ETF | Very Low | New York, NY | 2026-11-09 | |
| 750 | $2.4K | 0.0% | Growth | Medium | London, United Kingdom | 2026-11-06 | |
| 11 | $36 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 |